Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 2, 2007, Pages

  Anderzhanova, Elmira ^a   Covasa, Mihai ^b   Hajnal, Andras ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

CCK 1 receptor; No net flux microdialysis; Obesity; Overeating; Type 2 diabetes

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; DOPAMINE; POTASSIUM;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; GROUPS BY AGE; HORMONAL REGULATION; IN VIVO STUDY; INSULIN RESISTANCE; LEAN BODY WEIGHT; LONG EVANS RAT; MALE; METABOLIC REGULATION; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; OBESITY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; STRAIN DIFFERENCE;

3,4-DIHYDROXYPHENYLACETIC ACID; AGE FACTORS; ANIMALS; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DOPAMINE; EXTRACELLULAR SPACE; FEEDING BEHAVIOR; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; INSULIN RESISTANCE; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; OBESITY; POTASSIUM; RATS; RATS, INBRED OLETF; RATS, LONG-EVANS;

EID: 34547615730     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00301.2007     Document Type: Article

References (78)

1. Baptista T. Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatr Scand 100: 3-16, 1999.
2. Bednar I, Carrer H, Qureshi GA, Sodersten P. Dopamine D1 or D2 antagonists enhance inhibition of consummatory ingestive behavior by CCK-8. Am J Physiol Regul Integr Comp Physiol 269: R896-R903, 1995.
3. Beinfeld MC. What we know and what we need to know about the role of endogenous CCK in psychostimulant sensitization. Life Sci 73: 643-654, 2003.
4. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28: 309-369, 1998.
5. Berthoud HR. Multiple neural systems controlling food intake and body weight. Neurosci Biobehav Rev 26: 393-428, 2002.
6. Bi S, Ladenheim EE, Schwartz GJ, Moran TH. A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. Am J Physiol Regul Integr Comp Physiol 281: R254-R260, 2001.
7. Bungay PM, Morrison PF, Dedrick RL. Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci 46: 105-119, 1990.
8. Bungay PM, Newton-Vinson P, Isele W, Garris PA, Justice JB. Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J Neurochem 86: 932-946, 2003.
9. Chefer VI, Shippenberg TS. Changes in basal and cocaine-evoked extracellular dopamine uptake and release in the rat nucleus accumbens during early abstinence from cocaine: quantitative determination under transient conditions. Neuroscience 112: 907-919, 2002.
10. Chefer VI, Zapata A, Shippenberg TS, Bungay PM. Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens. J Neurosci Methods 155: 187-193, 2006.
11. Chen D, Wang MW. Development and application of rodent models for type 2 diabetes. Diabetes Obes Metab 7: 307-317, 2005.
12. Chen KC. Evidence on extracellular dopamine level in rat striatum: implications for the validity of quantitative microdialysis. J Neurochem 92: 46-58, 2005.
13. Chen KC. Preferentially impaired neurotransmitter release sites not their discreteness compromise the validity of microdialysis zero-net-flux method. J Neurochem 92: 29-45, 2005.
14. Conway B, Rene A. Obesity as a disease: no lightweight matter. Obes Rev 5: 145-151, 2004.
15. Costa RM, Gutierrez R, de Araujo IE, Coelho MR, Kloth AD, Gainetdinov RR, Caron MG, Nicolelis MA, Simon SA. Dopamine levels modulate the updating of tastant values. Genes Brain Behav 6: 314-320, 2006.
16. Covasa M, Ritter RC. Attenuated satiation response to intestinal nutrients in rats that do not express CCK-A receptors. Peptides 22: 1339-1348, 2001.
17. Crawley JN. Cholecystokinin-dopamine interactions. Trends Pharmacol Sci 12: 232-236, 1991.
18. Dawson LA, Routledge C. Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats. Br J Pharmacol 116: 3260-3264, 1995.
19. De Jonghe BC, Hajnal A, Covasa M. Increased oral and decreased intestinal sensitivity to sucrose in obese, prediabetic CCK-A receptor-deficient OLETF rats. Am J Physiol Regul Integr Comp Physiol 288: R292-R300, 2005.
20. De Jonghe BC, Hajnal A, Covasa M. Increased sensitivity to D1 and D2 receptor antagonism in sucrose feeding OLETF rats. Society for the Study of Ingestive Behavior: Annual Meeting 2005. San Diego, CA: Academic, 2005, p. 329-392.
21. Drewnowski A. Energy density, palatability, and satiety: implications for weight control. Nutr Rev 56: 347-353, 1998.
22. Erecinska M, Pastuszko A, Wilson DF, Nelson D. Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects on amines and amino acids. J Neurochem 49: 1258-1265, 1987.
23. Feifel D, Shilling PD, Kuczenski R, Segal DS. Altered extracellular dopamine concentration in the brains of cholecystokinin-A receptordeficient rats. Neurosci Lett 348: 147-150, 2003.
24. Figlewicz DP, Patterson TA, Johnson LB, Zavosh A, Israel PA, Szot P. Dopamine transporter mRNA is increased in the CNS of Zucker fatty (fa/fa) rats. Brain Res Bull 46: 199-202, 1998.
25. French SA, Story M, Jeffery RW. Environmental influences on eating and physical activity. Annu Rev Public Health 22: 309-335, 2001.
26. Garcia BG, Wei Y, Moron JA, Lin RZ, Javitch JA, Galli A. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol Pharmacol 68: 102-109, 2005.
27. Gerhardt GA, Maloney RE Jr. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats. Brain Res 816: 68 -77, 1999.
28. Hajnal A, Covasa M, Bello NT. Altered taste sensitivity in obese, pre-diabetic OLETF rats lacking CCK-1 receptors. Am J Physiol Regul Integr Comp Physiol 289: R1675-R1686, 2005.
29. Hajnal A, Mark GP, Rada PV, Lenard L, Hoebel BG. Norepinephrine microinjections in the hypothalamic paraventricular nucleus increase extracellular dopamine and decrease acetylcholine in the nucleus accumbens: relevance to feeding reinforcement. J Neurochem 68: 667-674, 1997.
30. Hajnal A, Norgren R. Accumbens dopamine mechanisms in sucrose intake. Brain Res 904: 76-84, 2001.
31. Hamdi A, Porter J, Prasad C. Decreased striatal D2 dopamine receptors in obese Zucker rats: changes during aging. Brain Res 589: 338-340, 1992.
32. Hamilton ME, Redondo JL, Freeman AS. Overflow of dopamine and cholecystokinin in rat nucleus accumbens in response to acute drug administration. Synapse 38: 238-242, 2000.
33. Hernandez L, Hoebel BG. Feeding and hypothalamic stimulation increase dopamine turnover in the accumbens. Physiol Behav 44: 599-606, 1988.
34. Hill DR, Shaw TM, Graham W, Woodruff GN. Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125IBolton Hunter CCK-8 and 3H-MK-329. J Neurosci 10: 1070 -1081, 1990.
35. Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science 280: 1371-1374, 1998.
36. Hokfelt T, Rehfeld JF, Skirboll L, Ivemark B, Goldstein M, Markey K. Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature 285: 476-478, 1980.
37. Hornykiewicz O. Biochemical aspects of Parkinson's disease. Neurology 51: S2-S9, 1998.
38. Huang XF, Yu Y, Zavitsanou K, Han M, Storlien L. Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity. Brain Res Mol Brain Res 135: 150-161, 2005.
39. Huang XF, Zavitsanou K, Huang X, Yu Y, Wang H, Chen F, Lawrence AJ, Deng C. Dopamine transporter and D2 receptor binding densities in mice prone or resistant to chronic high fat diet-induced obesity. Behav Brain Res 175: 415-419, 2006.
40. Hurd YL, Lindefors N, Brodin E, Brene S, Persson H, Ungerstedt U, Hokfelt T. Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission. Brain Res 578: 317-326, 1992.
41. Kariya K, Tanaka J, Nomura M. Systemic administration of CCK-8S, but not CCK-4, enhances dopamine turnover in the posterior nucleus accumbens: a microdialysis study in freely moving rats. Brain Res 657: 1-6, 1994.
42. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima fatty (OLETF) strain. Diabetes 41: 1422-1428, 1992.
43. Kelley AE. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 27: 765-776, 2004.
44. Ladurelle N, Durieux C, Roques BP, Dauge V. Different modifications of the dopamine metabolism in the core and shell parts of the nucleus accumbens following CCK-A receptor stimulation in the shell region. Neurosci Lett 178: 5-10, 1994.
45. Levin BE, Triscari J, Sullivan AC. The effect of diet and chronic obesity on brain catecholamine turnover in the rat. Pharmacol Biochem Behav 24: 299-304, 1986.
46. Meguid MM, Fetissov SO, Varma M, Sato T, Zhang L, Laviano A, Rossi-Fanelli F. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 16: 843-857, 2000.
47. Meites J. Role of hypothalamic catecholamines in aging processes. Acta Endocrinol (Copenh) 125 Suppl 1: 98-103, 1991.
48. Moran TH. Cholecystokinin and satiety: current perspectives. Nutrition 16: 858-865, 2000.
49. Moran TH, Bi S. Hyperphagia and obesity of OLETF rats lacking CCK1 receptors: developmental aspects. Dev Psychobiol 48: 360-367, 2006.
50. Olson RJ, Justice JB Jr. Quantitative microdialysis under transient conditions. Anal Chem 65: 1017-1022, 1993.
51. Pan WH, Lee JC. Determination of microdialysis extraction fraction of cocaine by the no net flux method under high, low, and zero steady-state cocaine concentrations in rats. Brain Res 686: 249 -253, 1995.
52. Parsons LH, Justice JB Jr. Extracellular concentration and in vivo recovery of dopamine in the nucleus accumbens using microdialysis. J Neurochem 58: 212-218, 1992.
53. Patterson TA, Brot MD, Zavosh A, Schenk JO, Szot P, Figlewicz DP. Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 68: 11-20, 1998.
54. Paxinos G, Watson CA. The Rat Brain in Stereotaxic Coordinates. Sydney, Australia: Academic, 1997.
55. Pecina S, Cagniard B, Berridge KC, Aldridge JW, Zhuang X. Hyperdopaminergic mutant mice have higher "wanting" but not "liking" for sweet rewards. J Neurosci 23: 9395-9402, 2003.
56. Pothos EN. Regulation of dopamine quantal size in midbrain and hippocampal neurons. Behav Brain Res 130: 203-207, 2002.
57. Prentice AM, Jebb SA. Fast foods, energy density and obesity: a possible mechanistic link. Obes Rev 4: 187-194, 2003.
58. Ramakrishnan R, Nazer MY, Suthanthirarajan N, Namasivayam A. An experimental analysis of the catecholamines in hyperglycemia and acidosis induced rat brain. Int J Immunopathol Pharmacol 16: 233-239, 2003.
59. 2+-/calmodulin-dependent protein kinase II in the modulation of indolamines in diabetic and hyperglycemic rats. J Neurosci Res 80: 518-528, 2005.
60. Roth GS, Joseph JA. Age-related changes in transcriptional and posttranscriptional regulation of the dopaminergic system. Life Sci 55: 2031-2035, 1994.
61. Rotzinger S, Bush DE, Vaccarino FJ. Cholecystokinin modulation of mesolimbic dopamine function: regulation of motivated behaviour. Pharmacol Toxicol 91: 404-413, 2002.
62. Seroogy K, Schalling M, Brene S, Dagerlind A, Chai SY, Hokfelt T, Persson H, Brownstein M, Huan R, Dixon J, Filer D, Schlessinger D, Goldstein M. Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry. Exp Brain Res 74: 149-162, 1989.
63. Simasko SM, Wiens J, Karpiel A, Covasa M, Ritter RC. Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons. Am J Physiol Regul Integr Comp Physiol 283: R1303-R1313, 2002.
64. Sorensen LB, Moller P, Flint A, Martens M, Raben A. Effect of sensory perception of foods on appetite and food intake: a review of studies on humans. Int J Obes Relat Metab Disord 27: 1152-1166, 2003.
65. Stanford JA, Currier TD, Purdom MS, Gerhardt GA. Nomifensine reveals age-related changes in K(+-)-evoked striatal DA overflow in F344 rats. Neurobiol Aging 22: 495-502, 2001.
66. Szczypka MS, Mandel RJ, Donahue BA, Snyder RO, Leff SE, Palmiter RD. Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice. Neuron 22: 167-178, 1999.
67. Szczypka MS, Rainey MA, Palmiter RD. Dopamine is required for hyperphagia in Lep(ob/ob) mice. Nat Genet 25: 102-104, 2000.
68. Takiguchi S, Takata Y, Funakoshi A, Miyasaka K, Kataoka K, Fujimura Y, Goto T, Kono A. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene 197: 169-175, 1997.
69. Ukkola O, Bouchard C. Role of candidate genes in the responses to long-term overfeeding: review of findings. Obes Rev 5: 3-12, 2004.
70. Vaccarino FJ, Vaccarino AL. Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: differential effects on brain stimulation reward. Neurosci Lett 97: 151-156, 1989.
71. Voigt M, Wang RY, Westfall TC. Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro. J Pharmacol Exp Ther 237: 147-153, 1986.
72. Volkow ND, Wang GJ, Maynard L, Jayne M, Fowler JS, Zhu W, Logan J, Gatley SJ, Ding YS, Wong C, Pappas N. Brain dopamine is associated with eating behaviors in humans. Int J Eat Disord 33: 136-142, 2003.
73. Wang GJ, Volkow ND, Fowler JS. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets 6: 601-609, 2002.
74. Wang Y, Perng SL, Lin JC, Tsao WL. Cholecystokinin facilitates methamphetamine-induced dopamine overflow in rat striatum and fetal ventral mesencephalic grafts. Exp Neurol 130: 279-287, 1994.
75. Weller A. The ontogeny of postingestive inhibitory stimuli: examining the role of CCK. Dev Psychobiol 48: 368-379, 2006.
76. Yeomans MR, Blundell JE, Leshem M. Palatability: response to nutritional need or need-free stimulation of appetite? Br J Nutr 92 Suppl 1: S3-S14, 2004.
77. Yoshida M, Yokoo H, Mizoguchi K, Kawahara H, Tsuda A, Nishikawa T, Tanaka M. Eating and drinking cause increased dopamine release in the nucleus accumbens and ventral tegmental area in the rat: measurement by in vivo microdialysis. Neurosci Lett 139: 73-76, 1992.
78. Zhang W, Segura BJ, Mulholland MW. Cholecystokinin-8 induces intracellular calcium signaling in cultured myenteric neurons from neonatal guinea pigs. Peptides 23: 1793-1801, 2002.